Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network (Q36671746)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 December 2006

Language	Label	Description	Also known as
English	Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network	scientific article published on 4 December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

Europe PubMed Central

Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

Robert F Lemanske

4

object named as

Robert F Lemanske

1 reference

Europe PubMed Central

15 August 2017

PMC publication ID

author name string

Loren C Denlinger

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Christine A Sorkness

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Vernon M Chinchilli

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

4 December 2006

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

119

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3-11; quiz 12-3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

beta-Adrenergic receptor polymorphisms and response to salmeterol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Effect of long‐acting β2 agonists on exacerbation rates of asthma in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Tucson Children's Respiratory Study: 1980 to present

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Variability and lack of predictive ability of asthma end-points in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

30 September 2017

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Daily inhaled corticosteroid treatment should not be prescribed for mild persistent asthma. Con.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Does mild persistent asthma require regular treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Daily versus as-needed corticosteroids for mild persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Within- and between-day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Systemic effect comparisons of six inhaled corticosteroid preparations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

The clinical trials in the initial five-year award period of the Asthma Clinical Research Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742212

20 September 2018

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of lung function in awake 2-4-year-old asthmatic children during methacholine challenge and acute asthma: a comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus whole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term inhaled corticosteroids in preschool children at high risk for asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17141853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JACI.2006.10.015

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36671746&oldid=2180924829"